Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review

Clinical Lung Cancer

Volumn 17, Issue 5, 2016, Pages e141-e149

  Chen, Hanbo ^a   Louie, Alexander V ^a,b   Boldt, R Gabriel ^a   Rodrigues, George B ^a   Palma, David A ^a   Senan, Suresh ^b  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Patient reported outcome; Prospective studies; Radiosurgery; SABR; Surgery

Indexed keywords

ARTICLE; CLINICAL OUTCOME; CYBERKNIFE; DETERIORATION; DYSPNEA; EARLY CANCER; EMBASE; EUROPE; FATIGUE; HUMAN; LINEAR ACCELERATOR; MEDLINE; NON SMALL CELL LUNG CANCER; NORTH AMERICA; PROSPECTIVE STUDY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; STATISTICAL SIGNIFICANCE; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC BODY RADIATION THERAPY; STUDY DESIGN; SYSTEMATIC REVIEW; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; RADIOSURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; DYSPNEA; FATIGUE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; QUALITY OF LIFE; RADIOSURGERY;

EID: 84953792365     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2015.12.009     Document Type: Article

References (32)

1. 1 Verstegen, N.E., Lagerwaard, F.J., Hashemi, S.M., Dahele, M., Slotman, B.J., Senan, S., Patterns of disease recurrence after SABR for early stage non-small-cell lung cancer: optimizing follow-up schedules for salvage therapy. J Thorac Oncol 10 (2015), 1195–1200.
2. 2 Palma, D., Visser, O., Lagerwaard, F.J., Belderbos, J., Slotman, B.J., Senan, S., Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 28 (2010), 5153–5159.
3. 3 Palma, D., Visser, O., Lagerwaard, F.J., Belderbos, J., Slotman, B., Senan, S., Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 101 (2011), 240–244.
4. 4 Timmerman, R., Paulus, R., Galvin, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303 (2010), 1070–1076.
5. 5 Haasbeek, C.J., Palma, D., Visser, O., Lagerwaard, F.J., Slotman, B., Senan, S., Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol 23 (2012), 2743–2747.
6. 6 Montazeri, A., Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes, 7, 2009, 102.
7. 7 Schnipper, L.E., Davidson, N.E., Wollins, D.S., et al. American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options. J Clin Oncol 33 (2015), 2563–2577.
8. 8 Gazala, S., Pelletier, J.S., Storie, D., Johnson, J.A., Kutsogiannis, D.J., Bedard, E.L., A systematic review and meta-analysis to assess patient-reported outcomes after lung cancer surgery. Scientific World Journal, 2013, 2013, 789625.
9. 9 Poghosyan, H., Sheldon, L.K., Leveille, S.G., Cooley, M.E., Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review. Lung Cancer 81 (2013), 11–26.
10. 10 Ubels, R.J., Mokhles, S., Andrinopoulou, E.R., et al. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer. Radiat Oncol, 10, 2015, 98.
11. 11 van der Voort van Zyp, N.C., Prevost, J.B., van der Holt, B., et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 77 (2010), 31–37.
12. 12 Widder, J., Postmus, D., Ubbels, J.F., Wiegman, E.M., Langendijk, J.A., Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys 81 (2011), e291–e297.
13. 13 Videtic, G.M., Reddy, C.A., Sorenson, L., A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer. Support Care Cancer 21 (2013), 211–218.
14. 14 Lagerwaard, F.J., Aaronson, N.K., Gundy, C.M., Haasbeek, C.J., Slotman, B.J., Senan, S., Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. J Thorac Oncol 7 (2012), 1148–1154.
15. 15 Jain, S., Poon, I., Soliman, H., et al. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life. Radiother Oncol 108 (2013), 320–325.
16. 16 Sun, V., Kim, J.Y., Williams, A.C., Raz, D.J., Sampath, S., Ferrell, B., Quality of life and symptoms following stereotactic body radiotherapy in early-stage lung cancer patients. J Commun Support Oncol 12 (2014), 407–414.
17. 17 Ferrero, C., Badellino, S., Filippi, A.R., et al. Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: a prospective study. Lung Cancer 89 (2015), 350–356.
18. 18 Mathieu, D., Campeau, M.P., Bahig, H., et al. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy. Pract Radiat Oncol 5 (2015), e365–e373.
19. 19 Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993), 365–376.
20. 20 Bergman, B., Aaronson, N.K., Ahmedzai, S., Kaasa, S., Sullivan, M., The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer 30A (1994), 635–642.
21. 21 Cella, D.F., Bonomi, A.E., Lloyd, S.R., Tulsky, D.S., Kaplan, E., Bonomi, P., Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12 (1995), 199–220.
22. 22 Hollen, P.J., Gralla, R.J., Kris, M.G., et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73 (1994), 2087–2098.
23. 23 Tantucci, C., Modina, D., Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis 7 (2012), 95–99.
24. 24 Bridevaux, P.O., Gerbase, M.W., Probst-Hensch, N.M., Schindler, C., Gaspoz, J.M., Rochat, T., Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 63 (2008), 768–774.
25. 25 Atherton, P.J., Watkins-Bruner, D.W., Gotay, C., et al. The complementary nature of patient-reported outcomes and adverse event reporting in cooperative group oncology clinical trials: a pooled analysis (NCCTG N0591). J Pain Symptom Manage 50 (2015), 470–479 e9.
26. 26 Fagundes, C.P., Shi, Q., Vaporciyan, A.A., et al. Symptom recovery after thoracic surgery: measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg 150 (2015), 613–619 e2.
27. 27 Chang, J.Y., Senan, S., Paul, M.A., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol 16 (2015), 630–637.
28. 28 Louie, A.V., Palma, D.A., Dahele, M., Rodrigues, G.B., Senan, S., Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons. Radiother Oncol 114 (2015), 138–147.
29. 29 Hollen, P.J., Gralla, R.J., Comparison of instruments for measuring quality of life in patients with lung cancer. Semin Oncol 23 (1996), 31–40.
30. 30 Oshima Lee, E., Emanuel, E.J., Shared decision making to improve care and reduce costs. N Engl J Med 368 (2013), 6–8.
31. 31 Stacey, D., Samant, R., Bennett, C., Decision making in oncology: a review of patient decision aids to support patient participation. CA Cancer J Clin 58 (2008), 293–304.
32. 32 Glance, L.G., Osler, T.M., Neuman, M.D., Redesigning surgical decision making for high-risk patients. N Engl J Med 370 (2014), 1379–1381.